AC
AMAM

Aaron Cowen’s Ambrx Biopharma Inc AMAM Stock Holding History

Aaron Cowen’s Portfolio AMAM Stock Details AMAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,491,832
Closed -$1.61M – 110
2022
Q3 		$1.61M Hold
1,491,832
– – 0.07% 67
2022
Q2 		$3.95M Hold
1,491,832
– – 0.15% 69
2022
Q1 		$6.15M Buy
1,491,832
+434,097
+41% +$2.22M 0.19% 60
2021
Q4 		$9.55M Buy
+1,057,735
New +$11.8M 0.18% 63
2021
Q3 		– Sell
-1,169,529
Closed -$22.9M – 136
2021
Q2 		$22.9M Buy
+1,169,529
New +$19.9M 0.34% 59

Other funds holding AMAM

DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
AGM
Alpine Global Management New York $615M AUM 34.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return

Aaron Cowen's AMAM Position: Q4 2022 in Review

Aaron Cowen sold out of Ambrx Biopharma Inc (AMAM) in Q4 2022, closing a stake of 1,491,832 shares — an estimated $1.61M sold.

Aaron Cowen first reported a position in AMAM in Q2 2021 and held it in 5 quarters. The position peaked at $22.9M in Q2 2021. 18 funds tracked by Wall St. Rank hold AMAM as of Q4 2022.

  • Aaron Cowen reported no remaining Ambrx Biopharma Inc position as of Q4 2022 after selling out during the quarter.
  • Aaron Cowen sold 1,491,832 Ambrx Biopharma Inc shares in Q4 2022, an estimated $1.61M.
  • Aaron Cowen first reported a position in Ambrx Biopharma Inc in Q2 2021 and held it in 5 quarters.
  • Aaron Cowen's Ambrx Biopharma Inc position peaked at $22.9M in Q2 2021.
  • 18 funds tracked by Wall St. Rank held Ambrx Biopharma Inc as of Q4 2022.

Based on Suvretta Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.